Skip to main content

Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • India evolving as antimicrobial stewardship

    Study finds that in contrast to developed countries that kept resistance levels under control, a considerable increase in resistance to various classes of antibiotics occurred in ESKAPE pathogens in India over the 2010-2020 decade. The study is published in the International Journal of Antimicrobial Agents.

  • WHO adds an HPV vaccine for single-dose use
    WHO announced that a fourth WHO-prequalified human papillomavirus vaccine product, Cecolin has been confirmed for use in a single-dose schedule. The decision is made based on new data on the product that fulfilled the criteria set out in the WHO 2022 recommendations for alternative, off-label use of HPV vaccines in single-dose schedules.
  • Union Health Minister Unveils Key Initiatives to boost Nutrition Support for TB Patients and their Families
    Underscoring Indias resolute commitment to end TB, Shri Nadda announced that Nutrition support under Ni-Kshay Poshan Yojana NPY has been increased from existing Rs. 500 per month, patient to Rs. 1,000/month, patient for entire duration of the treatment.
  • Inauguration of Honesty Cosmetics Bar at Kumar Organics
    Kumar organic Products Limited has inaugurated Honesty Cosmetics Bar at its Head Office in Jayanagar, Bangalore. Products displayed there are from Skin care, Hair care & Various formats of Depilatories. There are two Innovations too displayed they are Hair Wipe & Depilatory Tablet.
  • CDSCO under Ministry of Health & Family Welfare becomes Affiliate Member of the International Medical Device Regulators Forum

    The Ministry of Health and Family Welfare has introduced comprehensive regulations for medical devices aimed at aligning the country's regulatory framework with globally accepted standards. This initiative seeks to foster a regulatory ecosystem that promotes growth and innovation in the medical device sector.

  • Mankind Pharma to acquire Bharat Serums from Advent International for Rs 13,630 cr
    Mankind Pharma Limited has entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Limited from Advent International, one of the world’s largest and most experienced private equity investors, for an enterprise value of approx. INR 13,630 Crores, subject to closing related adjustments, the company said in a statement on exchanges.
  • Dr. Reddy’s Lab signs agreement with Gilead Sciences to manufacture and commercialise Lenacapavir

    Dr. Reddy’s Laboratories Ltd. announced that it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences Ireland UC for the manufacture and commercialisation of the drug, Lenacapavir, in India and 120 other countries.

  • 9th edition of Complete Companion for GPAT and Other Competitive Examination in Pharmacy published

    Dear All
    Most awaited and popular book with its latest 9th edition of Complete Companion for GPAT and Other Competitive Examination in Pharmacy published by Pearson Publication.
    For Purchase of Book Click on

    Features of book
    • All Important Theory for GPAT and other examinations in tabular, table as well as point form
    • More than 5000 Chapter wise MCQs
    • Dedicated NIPERJEE special module
    • Past Year Solved GPAT papers
    • Government Pharmacist, Drug inspector and Assistant Professor recruitment examination solved paper

  • Scientists discover gene responsible for rare, inherited eye disease
    Scientists at the National Eye Institute and their colleagues have identified a gene responsible for some inherited retinal diseases, which are a group of disorders that damage the eyes light-sensing retina and threatens vision. Though IRDs affect more than 2 million people worldwide, each individual disease is rare, complicating efforts to identify enough people to study and conduct clinical trials to develop treatment.
  • Scientists design new drug to fight malaria
    A team led by scientists at UC Riverside, UC Irvine, and Yale School of Medicine has now designed a new drug against malaria and identified its mechanism of action. The researchers found the drug, called MED6-189, is effective against drug-sensitive and drug-resistant P. falciparum strains in vitro as well as in a humanized mouse model the mice were engineered to have human blood.
Subscribe to Pharma News